etrozole versus hormone replacement therapy for frozen embryo transfer.
Not Applicable
- Conditions
- Health Condition 1: Z317- Encounter for procreative management and counseling for gestational carrier
- Registration Number
- CTRI/2023/06/053516
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women who will be undergoing frozen embryo transfer (FET)
Exclusion Criteria
Hydrosalpinx (not clipped or occluded); maternal medical disease; natural or modified natural FET cycles; cycles cancelled due to endometrial polyp, premature progesterone elevation or inadequate uterine blood flow.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical pregnacy rate, clinical pregnancy rate, abortion rateTimepoint: 4 weeks (At the end of ongoing frozen embryo transfer cycle), 8 weeks
- Secondary Outcome Measures
Name Time Method Endometrial thickness before transfer (mm). <br/ ><br>Serum Progesterone on day of transfer.Timepoint: 4 weeks (At the end of ongoing frozen embryo transfer cycle), 8 weeks